financetom
Business
financetom
/
Business
/
Market Chatter: Logility Supply Chain Solutions Exploring Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Logility Supply Chain Solutions Exploring Sale
Dec 11, 2024 2:20 PM

04:56 PM EST, 12/11/2024 (MT Newswires) -- Logility Supply Chain Solutions ( LGTY ) is exploring a sale, Reuters reported Wednesday, citing people familiar with the matter.

The supply chain software firm, which has a market value of about $400 million, has hired investment bank Lazard ( LAZ ) to assess takeover interest from potential buyers, the report said, citing the unnamed sources.

The process is at an early stage and a deal may not materialize, Reuters reported.

Logility didn't immediately respond to a request for comment by MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lucara Diamond Q2 Profit Doubles as Revenue Rises
Lucara Diamond Q2 Profit Doubles as Revenue Rises
Aug 12, 2024
07:27 AM EDT, 08/12/2024 (MT Newswires) -- Lucara Diamond ( LUCRF ) over the weekend said second-quarter profit doubled as revenue rose. The diamond miner, with operations in Botswana, said net income doubled to US$11.9 million, or US$0.03 per share, from US$6.1 million, or US$0.01 per share, last year. Revenue rose to US$41.3 million, from US$38.6 million. The company sold...
Bitdeer Technologies Group's Q2 Loss Narrows, Revenue Rises
Bitdeer Technologies Group's Q2 Loss Narrows, Revenue Rises
Aug 12, 2024
07:36 AM EDT, 08/12/2024 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) reported a Q2 loss Monday of $0.14 per diluted share, narrower than its loss of $0.36 a year earlier. Analysts polled by Capital IQ expected earnings of $0.01. Revenue for the quarter ended June 30 was $99.2 million, compared with $93.8 million a year earlier. Analysts surveyed...
Monday.com's Q2 Non-GAAP Net Income, Revenue Rise; 2024 Revenue Outlook Raised
Monday.com's Q2 Non-GAAP Net Income, Revenue Rise; 2024 Revenue Outlook Raised
Aug 12, 2024
07:29 AM EDT, 08/12/2024 (MT Newswires) -- Monday.com ( MNDY ) reported Q2 non-GAAP net income Monday of $0.94 per diluted share, up from $0.41 a year earlier. Analysts polled by Capital IQ expected $0.56. Revenue for the quarter ended June 30 was $236.1 million, compared with $175.7 million a year earlier. Analysts polled by Capital IQ expected $229.1 million....
Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy
Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy
Aug 12, 2024
07:34 AM EDT, 08/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday the US Food and Drug Administration has approved Yorvipath, the company's treatment for hypoparathyroidism, a rare endocrine disease, in adults. The approval is based on data from the global phase 2 and 3 trials. The company said it is finalizing the manufacturing of a commercial product...
Copyright 2023-2026 - www.financetom.com All Rights Reserved